Are pathogen-reduction technologies in blood transfusion worth the extra cost?

    PharmacoEconomics & Outcomes News volume 872, page3(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. LaFontaine PR, et al. Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review. Applied Health Economics and Health Policy : 8 Feb 2021. Available from: URL: https://doi.org/10.1007/s40258-020-00612-6

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Are pathogen-reduction technologies in blood transfusion worth the extra cost?. PharmacoEcon Outcomes News 872, 3 (2021). https://doi.org/10.1007/s40274-021-7476-7

    Download citation